Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
US11229632B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2019 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | Jun 4, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to combinations of a H3 antagonist and an antidepressant, which exhibit a synergistic wake promoting activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.